The Goldman Sachs Group Raises HUTCHMED (NASDAQ:HCM) Price Target to $17.00

HUTCHMED (NASDAQ:HCM – Free Report) had its target price upped by The Goldman Sachs Group from $15.00 to $17.00 in a research report report published on Friday morning, Benzinga reports. They currently have a neutral rating on the stock. HCM has been the topic of several other reports. Cantor Fitzgerald restated an overweight rating and […]

Leave a Reply

Your email address will not be published.

Previous post Celtics’ Payton Pritchard pushes through early-season struggles to reach breakthrough
Next post KVH Industries (NASDAQ:KVHI) Price Target Cut to $7.00 by Analysts at Needham & Company LLC